Screening: Misconceptions about Breast Cancer

US researchers Dr Kelly Ackerson and Dr Stephanie Preston reviewed 19 studies that between them explored the attitudes of 5,991 women to breast and cervical cancer screening. The studies, which covered the period 1994 to 2008, included women of all ages, from 14 year-old teenagers to women in their eighties.

“Our review showed that fear could motivate women to either seek screening or to avoid screening” says nurse researcher Dr Ackerson, an Assistant Professor at Western Michigan University, USA. Some women complied because they feared the disease and saw screening as routine care, but other women feared medical examinations, healthcare providers, tests and procedures and didn’t seek screening if their health was good.

Read more HERE!

GE Healthcare announced that the Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for DaTSCAN (Ioflupane I123 Injection) for priority review.  DaTSCAN is a radiopharmaceutical agent containing Ioflupane (¹²³I) in development for a proposed indication of the detection of loss of functional nigrostraiatal dopaminergic neurons by single photon emission computed tomography (SPECT) imaging in patients presenting with symptoms or signs suggestive of dopaminergic neurodegeneration.

Read More

Mammomat Inspiration, the digital mammography platform designed by Siemens and designaffairs, has received the iF Product Design Award 2009 and the red dot award: product design 2009. The device for the early detection of breast cancer shows that ease of use, high functionality, and unique design come together beautifully in a single medical engineering product.

Siemens Healthcare and designaffairs jointly designed the Mammomat Inspiration, the first mammography system to incorporate the MoodLight function. MoodLight is an LED glass panel that can be illuminated with freely selectable colors, producing a comfortable, relaxing effect on the patient.

Read More

 Biosense Webster, Inc., a leader in the diagnosis and treatment of cardiac arrhythmias, will be part of a public/private collaboration to fund a global clinical trial to compare catheter ablation to medical therapy in treating atrial fibrillation. AFib, as it is more commonly referred to, is the most prevalent cardiac arrhythmia (heart rhythm disorder), affecting an estimated 20 million people worldwide.  It is also one of the most common causes of stroke.

Read More

 Royal Philips Electronics announced an agreement to become an official medical equipment supplier of the New York Yankees. As part of the agreement, a state-of-the-art digital radiology system was installed inside Yankee Stadium, enabling onsite diagnosis of players by the Yankees medical team. In addition, potentially life-saving automated external defibrillators (AEDs) are available in both the player areas and in select locations in the Stadium, providing emergency care to fans that might be in need during a game.

Read More